News
EDA Chairman Discusses Enhanced International Cooperation and Investment Opportunities in the Egyptian Market with Representatives of Korean Companies
Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), held a meeting with representatives of several Korean companies participating in the Global Market Expansion Program (GMEP) to explore opportunities for introducing their products to the Egyptian market and review the regulatory requirements and applicable procedures governing the marketing of their products in the Arab Republic of Egypt. The meeting comes as part of the EDA’s ongoing efforts to promote investment and strengthen international cooperation in the healthcare sector.
The meeting was attended by Dr. Youngsun Yoo, CEO of Youth O’Clock; Dr. Hyunjung (John) Lim, CEO of Befor; Dr. Jungmin Byun, CEO of NX Biomed; Mr. Manhyung Han, Chief Strategy Officer at K-Style Hub; and Mr. Byungwoo Kang, Sales Manager at Wellbiz International. Also in attendance were Ms. Hania Tarek, Egypt Office Manager, and Ms. Mai Sorour, Regional Operations Coordinator at Plug and Play.
Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority, affirmed the EDA’s commitment to supporting cooperation with international companies seeking to enter the Egyptian market and providing the necessary technical and regulatory clarifications regarding product registration and marketing procedures. These efforts aim to facilitate procedures in accordance with the applicable regulatory frameworks and requirements, while enhancing the attractiveness of the Egyptian market for investment in health-related sectors.
For their part, the representatives of the Korean companies expressed their interest in investment opportunities in the Egyptian market and their aspiration to initiate the registration procedures for their products in Egypt. The meeting featured detailed discussions on the regulatory requirements, documentation, and procedures necessary for product registration, reflecting the companies’ commitment to understanding the regulatory frameworks governing market entry. They also highlighted the strategic importance of the Egyptian market as a gateway to African and European markets, offering promising opportunities for regional expansion, investment, and future cooperation.
The meeting also covered the regulatory pathways and requirements applicable to cosmetics, personal care products, and medical devices. Discussions further addressed procedures for importing finished products from Korea into Egypt, as well as the possibility of conducting packaging and repackaging operations locally, thereby supporting market expansion and opening new avenues for cooperation and investment.
This meeting forms part of the Egyptian Drug Authority’s broader efforts to strengthen engagement with investors and international companies and clarify the regulatory frameworks governing the marketing of products. These efforts seek to strike a balance between facilitating investment and ensuring compliance with regulatory requirements, safeguarding product quality and safety, protecting public health, and fostering a more attractive investment environment in Egypt.
Tags
EDA Chairman
Korean Companies